Amylin to Host Presentation at Credit Suisse Healthcare Conference
Rochester, NY 11/07/2009 01:20 PM GMT (TransWorldNews)
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) will present at the 18th Annual Credit Suisse Healthcare Conference on November 11th at 10:00 am (PT). The company's Senior Vice President of Finance and CFO, Mark Foletta, will host their presentation. The conference is being held in Phoenix at the Arizona Biltmore Resort & Spa. The webcast and recording will be available through the company's website. To access the live webcast please log on to the company's website 15 minutes prior to the presentation to register and download any necessary software.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
staff@pennystockprofessor.com
www.pennystockprofessor.com
Email Article to a friend
|
View Profile
Visit Blogs
|
NEWS ALERTS
Receive alerts for
Penny Stock Professor
to your inbox.
Sign up for TransWorldNews Alerts
TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
